Strata Skin Sciences Retained Earnings (Accumulated Deficit) 2010-2024 | SSKN
Strata Skin Sciences retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| Strata Skin Sciences Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2023 | $-238 |
| 2022 | $-227 |
| 2021 | $-222 |
| 2020 | $-219 |
| 2019 | $-215 |
| 2018 | $-211 |
| 2017 | $-204 |
| 2016 | $-211 |
| 2015 | $-207 |
| 2014 | $-182 |
| 2013 | $-168 |
| 2012 | $-142 |
| 2011 | $-120 |
| 2010 | $-99 |
| 2009 | $-79 |
| Strata Skin Sciences Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024-06-30 | $-242 |
| 2024-03-31 | $-241 |
| 2023-12-31 | $-238 |
| 2023-09-30 | $-234 |
| 2023-06-30 | $-233 |
| 2023-03-31 | $-230 |
| 2022-12-31 | $-227 |
| 2022-09-30 | $-227 |
| 2022-06-30 | $-226 |
| 2022-03-31 | $-224 |
| 2021-12-31 | $-222 |
| 2021-09-30 | $-221 |
| 2021-06-30 | $-220 |
| 2021-03-31 | $-221 |
| 2020-12-31 | $-219 |
| 2020-09-30 | $-219 |
| 2020-06-30 | $-217 |
| 2020-03-31 | $-216 |
| 2019-12-31 | $-215 |
| 2019-09-30 | $-214 |
| 2019-06-30 | $-213 |
| 2019-03-31 | $-212 |
| 2018-12-31 | $-211 |
| 2018-09-30 | $-234 |
| 2018-06-30 | |
| 2018-03-31 | $-232 |
| 2017-12-31 | $-204 |
| 2017-09-30 | $-228 |
| 2017-06-30 | $-214 |
| 2017-03-31 | $-213 |
| 2016-12-31 | $-211 |
| 2016-09-30 | $-210 |
| 2016-06-30 | $-208 |
| 2016-03-31 | $-209 |
| 2015-12-31 | $-207 |
| 2015-09-30 | $-207 |
| 2015-06-30 | $-197 |
| 2015-03-31 | $-190 |
| 2014-12-31 | $-182 |
| 2014-09-30 | $-178 |
| 2014-06-30 | $-176 |
| 2014-03-31 | $-176 |
| 2013-12-31 | $-168 |
| 2013-09-30 | $-164 |
| 2013-06-30 | $-156 |
| 2013-03-31 | $-149 |
| 2012-12-31 | $-142 |
| 2012-09-30 | $-136 |
| 2012-06-30 | $-131 |
| 2012-03-31 | $-125 |
| 2011-12-31 | $-120 |
| 2011-09-30 | $-115 |
| 2011-06-30 | $-109 |
| 2011-03-31 | $-104 |
| 2010-12-31 | $-99 |
| 2010-09-30 | $-94 |
| 2010-06-30 | $-89 |
| 2010-03-31 | $-84 |
| 2009-12-31 | $-79 |
| 2009-09-30 | $-74 |
| 2009-06-30 | $-69 |
| 2009-03-31 | $-65 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.013B | $0.033B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $11.978B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $6.055B | 188.82 |
| Hims & Hers Health (HIMS) | United States | $5.988B | 154.89 |
| Axonics (AXNX) | United States | $3.602B | 1762.00 |
| IRhythm Technologies (IRTC) | United States | $2.783B | 0.00 |
| Privia Health (PRVA) | United States | $2.736B | 228.00 |
| Enovis (ENOV) | United States | $2.646B | 17.94 |
| Omnicell (OMCL) | United States | $2.263B | 74.03 |
| Azenta (AZTA) | United States | $2.242B | 127.33 |
| 10x Genomics (TXG) | United States | $1.925B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.657B | 0.00 |
| Schrodinger (SDGR) | United States | $1.422B | 0.00 |
| Phreesia (PHR) | United States | $1.252B | 0.00 |
| Standard BioTools (LAB) | United States | $0.830B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.613B | 0.00 |
| Talkspace (TALK) | United States | $0.586B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.582B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.508B | 88.00 |
| Health Catalyst (HCAT) | United States | $0.506B | 0.00 |
| Pulmonx (LUNG) | United States | $0.298B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.248B | 0.00 |
| TruBridge (TBRG) | United States | $0.214B | 62.22 |
| P3 Health Partners (PIII) | United States | $0.142B | 0.00 |
| American Well (AMWL) | United States | $0.139B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.106B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.064B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.050B | 0.00 |
| Outset Medical (OM) | United States | $0.045B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| CareCloud (CCLD) | United States | $0.042B | 0.00 |
| Movano (MOVE) | United States | $0.028B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.018B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |